Top Page
Eurocell
(LSE:ECEL)
Eurocell (ECEL) vs. iShares MSCI United Kingdom ETF (EWC)
Eurocell Business Overview & Revenue Model
Eurocell Earnings Call Summary
Eurocell Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 357.90M | 364.50M | 381.20M | 339.80M | 257.90M |
| Gross Profit | 188.30M | 173.80M | 182.70M | 170.20M | 125.80M |
| EBITDA | 41.90M | 39.60M | 54.10M | 52.40M | 31.10M |
| Net Income | 10.50M | 9.60M | 19.70M | 21.10M | -2.20M |
Balance Sheet | |||||
| Total Assets | 223.80M | 223.80M | 254.90M | 240.20M | 201.40M |
| Cash, Cash Equivalents and Short-Term Investments | 400.00K | 400.00K | 5.10M | 6.60M | 7.10M |
| Total Debt | 62.90M | 58.60M | 84.00M | 76.30M | 65.40M |
| Total Liabilities | 118.40M | 109.50M | 140.00M | 134.00M | 114.20M |
| Stockholders Equity | 105.40M | 114.30M | 114.90M | 106.20M | 87.20M |
Cash Flow | |||||
| Free Cash Flow | 33.90M | 43.70M | 21.50M | 13.50M | 18.20M |
| Operating Cash Flow | 44.20M | 52.80M | 33.90M | 29.00M | 32.20M |
| Investing Cash Flow | -10.30M | -8.30M | -12.10M | -15.50M | -14.00M |
| Financing Cash Flow | -36.90M | -49.20M | -17.40M | -15.40M | -20.50M |
Eurocell Technical Analysis
Eurocell Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | 160.51M | 10.04 | 15.81% | 4.32% | -6.20% | 83.31% | |
69 Neutral | 834.03M | 16.99 | 5.21% | 3.10% | 5.88% | 107.36% | |
64 Neutral | 204.40M | 40.53 | 28.68% | 4.09% | -3.51% | -67.38% | |
64 Neutral | 123.06M | 12.94 | 0.00% | 3.14% | 19.86% | 19.09% | |
62 Neutral | £131.63M | 17.56 | 7.23% | 3.94% | 5.51% | -33.75% | |
54 Neutral | 231.17M | 65.73 | 1.68% | 4.05% | -6.12% | -86.98% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
Eurocell Corporate Events
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 9,806 of its ordinary shares through its broker, Berenberg. The shares were bought at prices ranging from 148.00 to 149.00 pence, with a volume-weighted average price of 148.31 pence per share. Following this transaction, the company’s issued share capital consists of 100,651,705 shares, with no shares held in treasury. This update affects the total number of voting rights in Eurocell, which shareholders can use to determine their interest in the company according to the Financial Conduct Authority’s Disclosure and Transparency Rules.
Eurocell plc has executed a share buyback program by purchasing 13,126 of its ordinary shares on the London Stock Exchange at a consistent price of 149.40 pence per share. This transaction impacts the company’s share capital, now consisting of 100,661,511 shares, which is relevant for shareholders in calculating their interests under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a buyback of 13,169 of its ordinary shares at a consistent price of 150 pence per share. This transaction, conducted through Berenberg, the company’s broker, results in Eurocell’s issued share capital consisting of 100,674,637 shares, all of which carry voting rights. The buyback aligns with the company’s strategic financial management and may impact shareholder calculations under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 13,334 of its ordinary shares at a price of 150 pence each on the London Stock Exchange. This transaction reduces the company’s issued share capital to 100,687,806 shares, impacting the total number of voting rights available to shareholders, which may influence their reporting obligations under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 13,238 of its ordinary shares at a consistent price of 150 pence each on the London Stock Exchange. This transaction reduces the company’s share capital to 100,701,140 shares, affecting the total number of voting rights and potentially impacting shareholder calculations under regulatory rules.
Eurocell plc has executed a share buyback program, purchasing 26,675 of its ordinary shares at a consistent price of 150 pence per share. This transaction, conducted through Berenberg, results in the company’s issued share capital consisting of 100,714,378 shares, which is significant for shareholders calculating their interests under regulatory rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 26,823 of its ordinary shares at a price of 149.50 pence each. This transaction leaves the company with an issued share capital of 100,737,012 shares, which is also the total number of voting rights. This move is part of Eurocell’s strategy to manage its capital structure and potentially enhance shareholder value.
Eurocell plc has executed a share buyback program, purchasing 27,959 of its ordinary shares at a price of 148.50 pence each on the London Stock Exchange. This transaction, facilitated by Berenberg, results in the company’s issued share capital consisting of 100,763,835 shares, with no shares held in treasury, impacting shareholder voting rights and potentially signaling confidence in the company’s financial health.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 27,729 of its ordinary shares at a price of 148.50 pence each. This transaction leaves the company with an issued share capital of 100,791,794 shares, which is also the total number of voting rights. The buyback is part of Eurocell’s strategy to manage its capital structure and potentially enhance shareholder value.
Eurocell plc has announced that five of its non-executive directors have purchased shares in the company as part of the Non-executive Directors’ Share Purchase Plan. This move, executed on August 4, 2025, aligns with the company’s governance practices and demonstrates the directors’ confidence in Eurocell’s future performance, potentially strengthening stakeholder trust and market positioning.
Eurocell plc has executed a share buyback program, purchasing 27,685 of its ordinary shares on the London Stock Exchange at a volume-weighted average price of 148.14 pence per share. This transaction reduces the company’s share capital to 100,819,523 shares, impacting the total number of voting rights and potentially influencing shareholder interest calculations under regulatory rules.
Eurocell plc, a company involved in the manufacturing and distribution of building products, announced a share buyback transaction. The company purchased 27,361 of its ordinary shares at a price of 148.50 pence each, resulting in a total issued share capital of 100,847,208 shares. This transaction impacts the company’s share capital structure and provides shareholders with updated information for regulatory compliance.
Eurocell plc has executed a share buyback program, purchasing 26,696 of its ordinary shares at a consistent price of 148 pence each on the London Stock Exchange. This transaction leaves the company with an issued share capital of 100,874,569 shares, impacting the total number of voting rights and potentially influencing shareholder interests under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 26,696 of its ordinary shares at a consistent price of 148 pence per share. This transaction reduces the company’s share capital to 100,874,569 shares, impacting shareholder voting rights calculations and potentially enhancing shareholder value.
Eurocell plc has executed a share buyback program, purchasing 26,302 of its ordinary shares at a consistent price of 150 pence each through its broker, Berenberg, on the London Stock Exchange. This transaction leaves Eurocell with an issued share capital of 100,901,265 shares, which will be used by shareholders to assess their interests under the Financial Conduct Authority’s rules, potentially impacting shareholder calculations and company transparency.
Eurocell plc has executed a share buyback program, purchasing 22,016 of its ordinary shares at a price of 149.60 pence each on the London Stock Exchange. This transaction, facilitated by Berenberg, results in a total issued share capital of 100,927,567 shares, impacting shareholder calculations under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 21,967 of its ordinary shares at a consistent price of 152 pence per share on the London Stock Exchange. This transaction reduces the company’s share capital to 100,949,583 shares, impacting the total number of voting rights and potentially affecting shareholder calculations under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 22,135 of its ordinary shares at a price of 153.25 pence each. This transaction, facilitated by Berenberg, reflects the company’s strategic move to manage its share capital, resulting in a total of 100,971,550 voting rights for shareholders. The buyback is part of Eurocell’s ongoing efforts to optimize its capital structure, potentially enhancing shareholder value and signaling confidence in its market position.
Eurocell plc has executed a share buyback program, purchasing 18,429 of its ordinary shares at a price of 152.25 pence per share on the London Stock Exchange. This transaction adjusts the company’s issued share capital to 100,993,685 shares, impacting the total number of voting rights and potentially influencing shareholder interest calculations under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 18,608 of its ordinary shares at a consistent price of 153.25 pence per share. This transaction, conducted through Berenberg, results in Eurocell having an issued share capital of 101,012,114 shares, which shareholders can use to calculate their voting rights under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 18,665 of its ordinary shares at a price of 152.75 pence each on the London Stock Exchange. This transaction results in the company’s issued share capital consisting of 101,030,722 shares, impacting voting rights and shareholder calculations under regulatory guidelines.
Eurocell plc, a company involved in the manufacturing and distribution of building products, has announced a share buyback transaction. The company purchased 16,801 of its ordinary shares at a price of 152 pence each on the London Stock Exchange, resulting in a total issued share capital of 101,049,387 shares. This move is part of Eurocell’s strategy to manage its capital structure and may impact shareholder voting rights as per the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 17,064 of its ordinary shares at a consistent price of 152 pence per share. This transaction, facilitated by Berenberg, results in Eurocell having an issued share capital of 101,066,188 shares, which is crucial for shareholders to calculate their interests under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 10,837 of its ordinary shares at a price of 152.50 pence each on the London Stock Exchange. This transaction reduces the company’s share capital to 101,083,252 shares, impacting the total number of voting rights and potentially influencing shareholder interest calculations under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 11,010 of its ordinary shares at a price of 153 pence each. This transaction leaves the company with an issued share capital of 101,094,089 shares, which shareholders can use to determine their interest in the company under regulatory rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 11,758 of its ordinary shares at a consistent price of 155 pence per share. This transaction leaves the company with a total of 101,105,099 shares in circulation, which shareholders can use to calculate their stake in accordance with the Financial Conduct Authority’s rules. The buyback is part of Eurocell’s efforts to manage its share capital and potentially enhance shareholder value.
Eurocell plc has executed a share buyback program, purchasing 11,367 of its ordinary shares at a consistent price of 155.50 pence per share on the London Stock Exchange. This transaction, facilitated by Berenberg, results in the company’s issued share capital consisting of 101,116,857 shares, impacting the total number of voting rights and potentially influencing shareholder notifications under regulatory rules.
Eurocell plc has executed a share buyback program, purchasing 11,565 of its ordinary shares at a price of 158.25 pence each. This transaction, facilitated by Berenberg, results in the company having no shares held in treasury, with an updated issued share capital of 101,128,224 shares. This move is likely to impact the company’s financial structure and shareholder value, aligning with regulatory requirements under UK law.
Eurocell plc has executed a share buyback program, purchasing 11,190 of its ordinary shares at a consistent price of 152 pence per share on the London Stock Exchange. This transaction reduces the company’s issued share capital to 101,139,789 shares, impacting shareholder calculations under the Financial Conduct Authority’s rules and potentially influencing market perceptions of the company’s financial health and shareholder value.
Eurocell plc has executed a share buyback program, purchasing 9,902 of its ordinary shares at a price of 155.70 pence per share. This transaction results in the company having no shares held in treasury, with a total issued share capital of 101,150,979 shares, impacting shareholder voting rights and transparency obligations.
Eurocell plc has executed a share buyback program, purchasing 9,969 of its ordinary shares at a consistent price of 157 pence per share on the London Stock Exchange. This transaction reduces the company’s issued share capital to 101,160,881 shares, impacting shareholder calculations for interest notifications under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 10,356 of its ordinary shares at a price of 158.70 pence per share. This transaction results in Eurocell having an issued share capital of 101,170,850 shares, which is crucial for shareholders to calculate their interests under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 10,045 of its ordinary shares at a consistent price of 158.75 pence per share on the London Stock Exchange. This transaction reduces the company’s issued share capital to 101,181,206 shares, impacting shareholder voting rights and potentially signaling confidence in the company’s financial health.
Eurocell plc has executed a share buyback program, purchasing 10,577 of its ordinary shares at a price of 157.50 pence each on the London Stock Exchange. This transaction results in the company’s issued share capital consisting of 101,191,251 shares, with no shares held in treasury, impacting shareholder calculations under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 13,020 of its ordinary shares at a price of 159.50 pence each on the London Stock Exchange. This transaction results in the company’s issued share capital consisting of 101,201,828 shares, which impacts the total number of voting rights and may affect shareholder notifications under regulatory rules.
Eurocell plc, a UK-based company, has announced a change in its major holdings due to an acquisition or disposal of financial instruments by Mudita Advisors LLP. This transaction has resulted in Mudita Advisors LLP holding 6% of the voting rights through financial instruments, an increase from their previous position of 5.19%. This change in holdings could impact Eurocell’s governance and decision-making processes, reflecting a significant shift in stakeholder influence.
Eurocell plc has executed a share buyback program, purchasing 14,790 of its ordinary shares at a consistent price of 161 pence per share on the London Stock Exchange. This transaction results in the company’s issued share capital consisting of 101,214,848 shares, with no shares held in treasury. The move is part of Eurocell’s strategy to manage its capital structure, potentially enhancing shareholder value and reflecting confidence in its financial position.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 14,890 of its own ordinary shares at a price of 158 pence per share. This transaction, conducted through Berenberg, results in Eurocell having an issued share capital of 101,229,638 shares, which is also the total number of voting rights. This buyback may influence shareholder calculations regarding their interests in the company under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program by purchasing 14,788 of its ordinary shares at a price of 157.50 pence per share. This transaction results in the company having no shares held in treasury, with a total issued share capital of 101,244,528 shares. The buyback is part of Eurocell’s strategy to manage its capital structure and enhance shareholder value, aligning with regulatory requirements under the UK’s Financial Conduct Authority’s Disclosure and Transparency Rules.
Eurocell plc has completed a share buyback transaction, purchasing 14,865 of its ordinary shares at a price of 154.30 pence each on the London Stock Exchange. This transaction reduces the number of shares in circulation, potentially enhancing shareholder value and reflecting confidence in the company’s financial health. The total number of voting rights in the company now stands at 101,259,316, which shareholders can use to determine their notification requirements under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 17,457 of its ordinary shares at a consistent price of 154 pence per share on the London Stock Exchange. This transaction leaves the company with no shares held in treasury, resulting in a total issued share capital of 101,274,181 shares, which aligns with regulatory requirements and may impact shareholder calculations regarding their interests in the company.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 17,457 of its ordinary shares at a price of 154.00 pence each. This transaction results in Eurocell having no shares held in treasury, with the total number of voting rights in the company now standing at 101,274,181. The buyback is part of Eurocell’s strategy to manage its share capital and potentially enhance shareholder value.
Eurocell plc has executed a share buyback program, purchasing 17,457 of its ordinary shares at a price of 153.39 pence each on the London Stock Exchange. This transaction results in the company having an issued share capital of 101,291,638 shares, which impacts the total number of voting rights and may affect shareholder notifications under regulatory rules.
Eurocell plc has executed a share buyback program, purchasing 18,578 of its ordinary shares on the London Stock Exchange. This transaction, facilitated by Berenberg, reflects the company’s strategic financial management, potentially enhancing shareholder value and adjusting its capital structure. The buyback leaves Eurocell with a total of 101,309,095 voting shares, which stakeholders can use to assess their interests under the Financial Conduct Authority’s rules.
Eurocell plc has executed a share buyback program, purchasing 18,395 of its ordinary shares on the London Stock Exchange through Berenberg, the company’s broker. This transaction is part of the company’s strategy to manage its capital structure and enhance shareholder value, resulting in an updated total of 101,327,673 voting rights in the company.
Eurocell plc, a company involved in a competitive audit tender process, has announced the resignation of PricewaterhouseCoopers (PwC) as its auditors, effective from the conclusion of its Annual General Meeting in May 2025. Following this, Deloitte LLP has been appointed as the new auditor for the financial year ending December 2025. This change is part of Eurocell’s strategic decision-making process to ensure effective auditing practices, with no additional matters requiring attention from shareholders or creditors.
Eurocell plc has repurchased 18,309 of its ordinary shares at a consistent price of 155 pence each on the London Stock Exchange as part of its Share Buyback Programme. This transaction leaves the company with no shares held in treasury, adjusting its issued share capital to 101,346,068 shares, which is crucial for shareholders in determining their voting rights and interests under regulatory rules.
Eurocell plc has executed a share buyback program, purchasing 17,963 of its ordinary shares at a consistent price of 155 pence per share on the London Stock Exchange. This transaction results in the company having no shares held in treasury and an issued share capital of 101,364,377 shares, impacting shareholder voting rights and transparency obligations.
Eurocell plc has executed a share buyback program, purchasing 17,588 of its ordinary shares at a consistent price of 157.25 pence per share. This transaction leaves the company with an issued share capital of 101,382,340 shares, impacting the total number of voting rights and potentially influencing shareholder interest notifications under regulatory rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 18,918 of its ordinary shares at a consistent price of 157 pence per share. This transaction results in the company having no shares held in treasury, with a total issued share capital of 101,399,928 shares. This move is part of Eurocell’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation, which may impact the company’s market positioning and shareholder calculations under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has announced the repurchase of 21,808 of its ordinary shares through Berenberg, acting as the company’s broker. This transaction is part of Eurocell’s Share Buyback Programme, which aims to optimize the company’s capital structure and potentially enhance shareholder value. Following this purchase, Eurocell’s issued share capital consists of 101,418,846 shares, with no shares held in treasury, impacting the total number of voting rights available to shareholders.
Eurocell plc has executed a share buyback program, purchasing 21,515 of its ordinary shares at a price of 156.75 pence each on the London Stock Exchange. This transaction leaves the company with no shares held in treasury, resulting in an issued share capital of 101,439,954 shares, which also represents the total number of voting rights. This move is part of Eurocell’s strategy to manage its capital structure and potentially enhance shareholder value.
Eurocell plc has executed a share buyback program, purchasing 21,515 of its ordinary shares at a consistent price of 156.75 pence per share on the London Stock Exchange. This transaction reduces the company’s total issued share capital to 101,439,954 shares, impacting shareholder voting rights calculations under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program by purchasing 21,820 of its ordinary shares at a price of 158 pence each. This transaction results in the company’s issued share capital comprising 101,461,469 shares, which is also the total number of voting rights in the company. This move is part of Eurocell’s strategy to manage its capital structure and potentially enhance shareholder value.
Eurocell plc has executed a share buyback program, purchasing 22,426 of its ordinary shares at a consistent price of 158 pence per share. This transaction reduces the company’s issued share capital to 101,483,289 shares, affecting the total number of voting rights and potentially influencing shareholder interest notifications under regulatory rules.
Eurocell, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 22,876 of its ordinary shares at a price of 157.50 pence each. This transaction leaves Eurocell with an issued share capital of 101,505,715 shares, which will be used by shareholders to determine their interests as per the Financial Conduct Authority’s Disclosure and Transparency Rules.
Eurocell plc has executed a share buyback program, purchasing 22,836 of its ordinary shares at a price of 157.45 pence each on the London Stock Exchange. This transaction leaves the company with an issued share capital of 101,528,591 shares, which stakeholders can use to calculate their interests under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 22,746 of its ordinary shares at a price of 153.48 pence per share. This transaction leaves the company with an issued share capital of 101,551,427 shares, which is significant for shareholders as it affects the calculation of their voting rights under the Financial Conduct Authority’s rules.
Eurocell plc has repurchased 20,220 of its ordinary shares at a price of 149.05 pence each, as part of a share buyback program executed through Berenberg, the company’s broker. This transaction results in the company having no shares held in treasury, with an issued share capital of 101,574,173 shares, impacting shareholder calculations under the Financial Conduct Authority’s rules.
Eurocell plc, a company involved in the manufacturing and supply of building products, has announced that five of its non-executive directors have purchased shares in the company. This move is part of the Non-executive Directors’ Share Purchase Plan, initially announced in February 2023. The transactions, which took place on June 3, 2025, were conducted on the London Stock Exchange, with each director acquiring shares at a price of £1.52. This purchase reflects a commitment from the company’s leadership and could indicate confidence in Eurocell’s future performance.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 19,153 of its ordinary shares at a price of 152.00 pence each. This transaction results in Eurocell having an issued share capital of 101,594,393 shares, which shareholders can use to calculate their interests in accordance with the Financial Conduct Authority’s rules.
Eurocell has announced that its Non-executive Directors have re-entered a share purchase plan, committing a portion of their net monthly fees to automatically purchase ordinary shares in the company. This move is designed to align the interests of the directors with the company and demonstrates their confidence in Eurocell’s future, with purchases scheduled at regular intervals over the coming months.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 19,243 of its ordinary shares at a price of 154.25 pence each. This transaction results in the company having a total of 101,613,546 shares in issue, with no shares held in treasury, impacting shareholders’ calculations under the Financial Conduct Authority’s rules.
Eurocell plc, a company listed on the London Stock Exchange, has executed a share buyback program, purchasing 19,205 of its ordinary shares at a consistent price of 154 pence each. This transaction leaves Eurocell with a total issued share capital of 101,632,789 shares, which will be used by shareholders to determine their voting rights and interests in accordance with the Financial Conduct Authority’s rules. The buyback reflects Eurocell’s strategic financial management, potentially impacting its market positioning and shareholder value.
Eurocell plc announced the granting of options under its Performance Share Plan 2025 to two of its directors, CEO Darren Waters and CFO Michael Scott. This move is part of the company’s strategy to align management incentives with shareholder interests, potentially impacting the company’s operational focus and market positioning by motivating key executives to drive long-term growth.
Eurocell plc has repurchased 18,578 of its ordinary shares at a price of 155 pence each on the London Stock Exchange as part of its Share Buyback Programme. This transaction reduces the company’s issued share capital to 101,651,994 shares, impacting shareholder voting rights and aligning with regulatory requirements.
Eurocell plc has repurchased 17,512 of its ordinary shares on the London Stock Exchange, with a volume-weighted average price of 152.91 pence per share. This transaction is part of the company’s Share Buyback Programme, which aims to optimize its capital structure and enhance shareholder value by reducing the number of shares in circulation, thus potentially increasing earnings per share.
Eurocell plc has executed a share buyback program, purchasing 16,993 of its ordinary shares on the London Stock Exchange at an average price of 149.97 pence per share. This transaction reduces the company’s share capital to 101,688,084 shares, impacting the total number of voting rights and potentially influencing shareholder calculations under the Financial Conduct Authority’s Disclosure and Transparency Rules.
Eurocell plc has repurchased 15,747 of its ordinary shares at a price of 149.50 pence per share on the London Stock Exchange. This transaction is part of the company’s Share Buyback Programme, which will result in a total issued share capital of 101,705,077 shares, providing shareholders with a clear denominator for calculating their interests in accordance with regulatory requirements.
Eurocell plc has executed a share buyback program, purchasing 17,120 of its ordinary shares at a price of 150.75 pence each on the London Stock Exchange. This transaction reduces the company’s issued share capital to 101,720,824 shares, impacting voting rights calculations for shareholders under the Financial Conduct Authority’s Disclosure and Transparency Rules.
Eurocell plc has executed a share buyback, purchasing 16,876 of its ordinary shares at a consistent price of 151 pence per share on the London Stock Exchange. This transaction leaves the company with a total issued share capital of 101,737,944 shares, which will be used by shareholders for transparency and disclosure calculations as per regulatory requirements.
Eurocell plc has announced a share buyback, purchasing 16,640 of its ordinary shares on the London Stock Exchange at a price of 147.72 pence per share. This transaction reduces the company’s treasury shares to zero and sets the total number of voting rights at 101,754,820, which is significant for shareholders in calculating their interests under regulatory rules.
Eurocell plc has executed a share buyback program, purchasing 16,770 of its ordinary shares at a consistent price of 145 pence per share on the London Stock Exchange. This transaction results in the company’s issued share capital consisting of 101,771,460 shares, which impacts the total number of voting rights and shareholder calculations under the Financial Conduct Authority’s Disclosure and Transparency Rules.
Eurocell plc has executed a share buyback program, purchasing 15,537 of its ordinary shares at a price of 146 pence each on the London Stock Exchange. This transaction reduces the company’s share capital to 101,788,230 shares, impacting the total number of voting rights and potentially influencing shareholder interest calculations under the Financial Conduct Authority’s rules.